Georgia Bio to Present Lifetime Achievement Award Posthumously to Lee Herron

Georgia Bio, the state’s life science trade association, will honor the late Lee Herron, an industry leader and long-time supporter of Georgia Bio, with its Lifetime Achievement Award at next week’s Georgia Life Sciences Summit which celebrates the contributions and achievements of Georgia leaders who have been instrumental in advancing the growth of the life sciences industry and elevating Georgia’s overall ecosystem. In its 35-year history, Georgia Bio has only ever presented five Lifetime Achievement awards.

 

Lee, who will long be remembered as a pillar and irreplaceable leader in the industry, retired from the Georgia Research Alliance (GRA) in the spring of 2024 after a 16-year career with the Alliance, most recently, Lee led GRA’s agricultural technology programs including the Greater Yield initiative. He directed its award-winning venture development program for 15 years, which helped to launch 200+ university-based companies that attracted more than $2 billion in equity investment. A seasoned executive, Lee harnessed his 20 years of entrepreneurial experience to help startups develop sound business strategies. Lee served in many community leadership capacities, including board positions for Georgia Bio and Southeast Life Sciences, the Global Center for Medical Innovation’s Industry Advisory Board, the Biolocity Oversight Committee, and the NSF Center for Cell Manufacturing Technology’s Commercialization Advisory Board.


“Lee was a true visionary whose passion and integrity touched everyone he met," says Georgia Bio President and CEO, Maria Thacker-Goethe. “His unwavering commitment to innovation and his profound impact on the life sciences industry will be felt for generations to come. We are honored to present him with this award posthumously.”


“The Georgia Research Alliance would not be what it is today without Lee Herron,” says GRA President and CEO Tim Denning, PhD. “Lee helped shape our program that moves university inventions to the marketplace — a program that he led and grew for 16 years. Countless technologies are at work in the world today, benefiting companies and consumers alike, because of Lee’s wisdom, guidance, and desire to make a difference.”


Prior to joining GRA, Lee managed the biosciences division of Georgia Tech’s Advanced Technology Development Center (ATDC) and founded four biosciences companies: SeaLite Sciences Inc., Biopool International Inc., CytRx Corporation, and Theragenics Corporation. Herron received a Doctor of Veterinary Medicine degree from the University of Georgia and completed an internship at Cornell University. He also studied experimental pathology at Emory University.


Lee passed away on July 12, 2024, after a long battle with cancer. He was a devout family man, husband to Rita Herron for 50 years, father to three children, and grandfather to eight children. He leaves behind a profound legacy and will be remembered by his friends and colleagues as a dear friend.


Award Presentation   


Georgia Bio will honor Lee at the opening reception for the organization’s largest annual gathering, the Georgia Life Sciences Summit, taking place on October 21 at the Sandy Springs Performing Arts Center from 5:00pm to 7:00pm.


# # #


About Georgia Bio



Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For over 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, strengthens the workforce pipeline, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org.

 

MEDIA CONTACT:

Melissa Carter

404-920-2043

mcarter@gabio.org

Georgia Life Sciences Joins National Coalition Urging Congressional Action on Key Innovation Policies

December 10, 2025
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.

GLS Joins Georgia Partners in Calling for Federal PBM Reform

December 7, 2025
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.

GLS’ President and CEO, Maria Thacker Goethe in December's issue of Georgia Trend

December 4, 2025
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
MORE POSTS